semaglutide cardiovascular risk outcomes align more closely with attained dose than achieved weight loss Effects of semaglutide on risk

In individuals with AD, GLP-1RAs did not exert disease-modifying effects on cognition

WERNERSVILLE, Pa

When anxiety tightens its grip, the last thing you need is another complicated solution

This mass can cause a total blockage, preventing anything from passing into the intestines

TRIUMPH-4's 28.7% average is approaching sleeve gastrectomy territory (2530%)

Adults who may be considered for GLP-1 weight loss treatment often include those who: Have a body mass index (BMI) in the overweight or obese range Have struggled to lose weight through diet and exercise alone Have related conditions such as prediabetes, insulin resistance, or metabolic syndrome Are looking for a medically supervised approach to weight management Eligibility is determined by a licensed medical provider after reviewing your health history, current medications, and overall goals